Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

FDG- and FLT-PET for early measurement of response to 37.5 mg per day of sunitinib in metastatic renal cell carcinoma

Kevin Horn, Jeffrey Yap, Neeraj Agarwal, Kathryn Morton, Dan Kadrmas, Britney Beardmore, Regan Butterfield, Ken Boucher and John Hoffman
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1213;
Kevin Horn
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey Yap
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neeraj Agarwal
4Medicine, University of Utah, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Morton
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Kadrmas
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britney Beardmore
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regan Butterfield
2Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Boucher
3Internal Medicine, University of Utah, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hoffman
1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1213

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Kevin Horn1,
  2. Jeffrey Yap1,
  3. Neeraj Agarwal4,
  4. Kathryn Morton1,
  5. Dan Kadrmas1,
  6. Britney Beardmore1,
  7. Regan Butterfield2,
  8. Ken Boucher3 and
  9. John Hoffman1
  1. 1Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT
  2. 2Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA
  3. 3Internal Medicine, University of Utah, Salt Lake City, UT
  4. 4Medicine, University of Utah, Salt Lake City, UT

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to May 2025

AbstractFullPdf
May 2015800
Jun 20152200
Jul 20153700
Aug 20151500
Sep 20152000
Oct 20152500
Nov 2015400
Dec 20151700
Jan 2016800
Feb 2016900
Mar 20161000
Apr 2016900
May 20161000
Jun 20161200
Jul 20161100
Aug 2016400
Sep 20161500
Oct 20161100
Nov 2016600
Dec 2016700
Jan 20173000
Feb 20171400
Mar 2017800
Apr 20171900
May 2017900
Jun 20171300
Jul 2017400
Aug 20171000
Sep 20172200
Oct 2017900
Nov 2017700
Dec 2017300
Jan 2018800
Feb 2018800
Mar 20181200
Apr 20181200
May 2018900
Jun 20181400
Jul 20181100
Aug 20181800
Sep 2018800
Oct 2018700
Nov 2018500
Jan 2019800
Feb 2019400
Mar 20191100
Apr 2019400
May 2019200
Jul 2019700
Aug 2019600
Sep 2019400
Oct 2019300
Dec 20191400
Jan 2020100
Feb 2020900
Mar 20203300
Apr 20201800
May 20201100
Jun 2020300
Jul 2020600
Aug 20202200
Sep 20202800
Oct 20201300
Nov 20202500
Dec 20201700
Jan 2021400
Feb 20211400
Mar 20212900
Apr 20212200
May 20211000
Jun 2021600
Jul 20212500
Aug 20214100
Sep 20211900
Oct 20212300
Nov 20217600
Dec 20214200
Jan 20228500
Feb 20222900
Mar 20222200
Apr 20222900
May 20223700
Jun 2022700
Jul 2022200
Aug 20221100
Sep 2022300
Oct 2022300
Dec 2022500
Jan 2023200
Feb 2023700
Mar 2023300
Apr 2023700
May 2023600
Jun 2023500
Jul 2023400
Aug 2023900
Sep 20231000
Oct 2023200
Nov 2023200
Dec 2023200
Jan 2024800
Feb 2024200
Mar 2024200
Apr 2024500
May 2024200
Jun 2024300
Jul 2024400
Aug 20241900
Sep 20241100
Oct 2024300
Nov 2024200
Dec 2024300
Feb 2025300
Mar 2025200
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG- and FLT-PET for early measurement of response to 37.5 mg per day of sunitinib in metastatic renal cell carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG- and FLT-PET for early measurement of response to 37.5 mg per day of sunitinib in metastatic renal cell carcinoma
Kevin Horn, Jeffrey Yap, Neeraj Agarwal, Kathryn Morton, Dan Kadrmas, Britney Beardmore, Regan Butterfield, Ken Boucher, John Hoffman
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1213;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG- and FLT-PET for early measurement of response to 37.5 mg per day of sunitinib in metastatic renal cell carcinoma
Kevin Horn, Jeffrey Yap, Neeraj Agarwal, Kathryn Morton, Dan Kadrmas, Britney Beardmore, Regan Butterfield, Ken Boucher, John Hoffman
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1213;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • The frequency and content of documentation for patients’ 131I therapies for checkpoint security agents: the final report of a national survey.
  • Physician and Nurse Radiation Exposure During the First Year of Performing I-131 mIBG Therapy
  • Impact of Inter-software and Inter-reader Agreement on FDG PET/CT Liver SULmean
Show more Oncology: Basic, Translational & Therapy

MTA I: Image-Guided Therapy Posters

  • Prognostic value of combined [99m]Tc-MAA-SPECT/CT and [18F]Fluoroethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization
  • Texture analysis for FMISO PET/CT in oncology patients receiving extra-beam radiation therapy
  • Tet-On regulating HSV-sr39tk suicide gene expressing mesenchymal stem cells with dual reporter system exert bystander effect on anaplastic thyroid cancer
Show more MTA I: Image-Guided Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire